High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis
BackgroundUrothelial carcinoma (UC) patients often bear clinical and genetic heterogeneity, which may differ in management and prognosis. Especially, patients with advanced/metastatic UC generally have a poor prognosis and survive for only few months. The Wnt/β-catenin signaling is found to be highl...
Main Authors: | Hong-Yue Lai, Chia-Chun Chiu, Yu-Hsuan Kuo, Hsin-Hwa Tsai, Li-Ching Wu, Wen-Hsin Tseng, Chien-Liang Liu, Chung-Hsi Hsing, Steven K. Huang, Chien-Feng Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-03-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.834249/full |
Similar Items
-
Overexpression of Pyruvate Dehydrogenase Kinase-3 Predicts Poor Prognosis in Urothelial Carcinoma
by: Yu-Hsuan Kuo, et al.
Published: (2021-09-01) -
Low expression of ZSCAN4 predicts unfavorable outcome in urothelial carcinoma of upper urinary tract and urinary bladder
by: Hong-Lin He, et al.
Published: (2023-02-01) -
Angiogenesis Driven by the CEBPD–hsa-miR-429–VEGFA Signaling Axis Promotes Urothelial Carcinoma Progression
by: Ti-Chun Chan, et al.
Published: (2022-02-01) -
The biological impacts of CEBPD on urothelial carcinoma development and progression
by: Ti-Chun Chan, et al.
Published: (2023-01-01) -
Upregulation of dihydropyrimidinase-like 3 (DPYSL3) protein predicts poor prognosis in urothelial carcinoma
by: Peir-In Liang, et al.
Published: (2023-06-01)